Sequences

Sample result

GLP-1, a diabetes hormone

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Patents

3,061 publications in 1,851 families match these filters.

  1. US 8759291-B22014-06-24

    Methods of treatment using exendin peptides or GLP-1 peptides

    Amylin Pharmaceuticals, LLC and AstraZeneca Pharmaceuticals LP

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  2. JP 2014516994-A2014-07-17

    GLUCOSE DEPENDENT INSULINOTROPIC POLYPEPTIDE ANALOGS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF

    Ma Tao,Xu Shusen,Liu Zhijun,Zhang Bo,Shen Ning,Yang Hai,Zhang Wei,Li Yuhua, Moon Sunghwan,Kim Maengsup

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  3. JP 2014520789-A2014-08-25

    NOVEL COMPOUNDS AND THEIR EFFECTS ON FEEDING BEHAVIOUR

    Imperial Innovations Limited

    Query Match 96.3%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  4. CARBOXYLIC ACID DERIVATIVES COMPRISING FOUR CYCLES ACTING AS GLP-1 RECEPTOR MODULATORS FOR THERAPY OF DISEASES SUCH AS DIABETES

    RECEPTOS, INC

    Query Match 96.3%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  5. JP 2014525430-A2014-09-29

    Pharmaceutical composition for use in the treatment of a neurodegenerative disease

    Sanofi-Aventis Deutschland GmbH,UNIVERSITY OF ULSTER

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  6. LONG-LIVED POLYNUCLEOTIDE MOLECULES

    MODERNA THERAPEUTICS INC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 25 to 54. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit   25 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 54
    

    30 of 30 identical, no gaps.

  7. US 8883723-B22014-11-11

    Conjugate of insulin and vitamin B12 for oral delivery

    Syracuse University

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  8. US 8895498-B22014-11-25

    GIP and exendin hybrid polypeptides

    AstraZeneca Pharmaceuticals, LP and Amylin Pharmaceuticals, LLC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  9. JP 2014227368-A2014-12-08

    Glucagon Analogue for Treatment of Diabetes and Hyperglycemic Condition

    Obihiro University of Agriculture and Veterinary Medicine

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  10. US 8906851-B22014-12-09

    Method for treating diabetes

    Amylin Pharmaceuticals, LLC and AstraZeneca Pharmaceuticals LP

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  11. EP 2817025-A22014-12-31

    TREATMENT OF HYPOGLYCEMIA

    SENEB BIOSCIENCES INC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  12. US 8940316-B22015-01-27

    Osmotic delivery comprising an insulinotropic peptide and uses thereof

    Intarcia Therapeutics, Inc.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  13. US 8946155-B22015-02-03

    Long-acting polypeptides and methods of producing and administering same

    OPKO Biologics Ltd.

    Query Match 96.3%Identity 100.0%Family of 14

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 14

    Grouped by the same title and applicant. No priority claim is on record.

  14. EP 2841090-A12015-03-04

    SITE-SPECIFIC ENZYMATIC MODIFICATION OF EXENDINS AND ANALOGS THEREOF

    AMYLIN PHARMACEUTICALS LLC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  15. JP 2015506926-A2015-03-05

    Anti-Diabetic Compounds

    CovX Technologies Ireland Limited,Pfizer Inc

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  16. Exendin-4 Peptide Analogues

    SANOFI

    Query Match 96.3%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  17. US 8980242-B22015-03-17

    Aliphatic prodrug linker

    Ascendis Pharma GmbH

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  18. US 8992886-B22015-03-31

    Cyclic peptide analogues for non-invasive imaging of pancreatic beta-cells

    Board of Regents, the University of Texas System

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  19. EP 2853536-A12015-04-01

    Long-acting erythropoietin polypeptides and uses thereof

    OPKO BIOLOG LTD

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  20. EP 2853541-A12015-04-01

    Long-acting polypeptides and uses thereof

    OPKO BIOLOG LTD

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  21. US 8999670-B22015-04-07

    Long-acting polypeptides and methods of producing same

    OPKO Biologics Ltd.

    Query Match 96.3%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  22. US 9034819-B22015-05-19

    Method of lowering cholesterol and triglycerides by administering exendins

    Amylin Pharmaceuticals, LLC and Astrazeneca Pharmaceuticals, LP

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  23. US 9040481-B22015-05-26

    Methods for treating steatotic disease

    The General Hospital Corporation

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  24. NOVEL COMPOUND FOR TREATMENT OF SEVERE HYPOGLYCEMIA

    LILLY CO ELI

    Query Match 96.3%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  25. EP 2911686-A12015-09-02

    PEPTIDES AND METHODS FOR PREVENTING ISCHEMIC TISSUE INJURY

    UNIV HEALTH NETWORK

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  26. US 9133260-B22015-09-15

    GIP analog and hybrid polypeptides with selectable properties

    Amylin Pharmaceuticals, LLC and AstraZeneca Pharmaceuticals LP

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  27. US 9163227-B22015-10-20

    Anti-diabetic compounds

    COVX TECHNOLOGIES IRELAND LIMITED

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  28. US 9187522-B22015-11-17

    GLP-1 receptor modulators

    Receptos, Inc.

    Query Match 96.3%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  29. US 9234023-B22016-01-12

    Glucagon-like peptide-1 glycopeptides

    Biousian Biosystems, Inc.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  30. WO 2016035820-A2016-03-10

    CENTRALLY-ACTING PEPITIDE DERIVATIVE AND MEDICAL COMPOSITION

    Tokyo University of Science Foundation

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  31. US 9289516-B22016-03-22

    Imaging beta cell mass

    The General Hospital Corporation

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  32. CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS

    MERCK SHARP & DOHME

    Query Match 96.3%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  33. US 9364519-B22016-06-14

    Pharmaceutical composition for use in the treatment of a neurodegenerative disease

    SANOFI-AVENTIS DEUTSCHLAND GMBH and UNIVERSITY OF ULSTER

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  34. GLP-1 RECEPTOR MODULATORS

    CELGENE INTERNAT II SARL

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  35. NOVEL COMPOUND FOR TREATMENT OF SEVERE HYPOGLYCEMIA

    Eli Lilly and Company

    Query Match 96.3%Identity 100.0%Family of 5

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 5

    Grouped by the same title and applicant. No priority claim is on record.

  36. MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF

    THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH

    Query Match 96.3%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  37. GIP AND GLP-1 CO-AGONIST COMPOUNDS

    LILLY CO ELI

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  38. MODIFIED THERAPEUTIC AGENTS, STAPLED PEPTIDE LIPID CONJUGATES, AND COMPOSITIONS THEREOF

    THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  39. PROTEASE RESISTANT PEPTIDES

    MEDIMMUNE LIMITED

    Query Match 96.3%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  40. US 9453062-B22016-09-27

    Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof

    Beijing Hanmi Pharmaceutical Co., Ltd.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  41. JP 2016531156-A2016-10-06

    MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF

    THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH, THE SCRIPPS RESEARCH INSTITUTE

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  42. US 9463174-B22016-10-11

    Pharmaceutical composition for the treatment of type-1 diabetes

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  43. EP 3077419-A12016-10-12

    G-PROTEIN COUPLED RECEPTOR AGONISTS AND METHODS

    INNOVATIVE TARGETING SOLUTIONS INC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  44. EP 3082056-A12016-10-19

    METHOD AND ELECTRONIC SYSTEM FOR PREDICTING AT LEAST ONE FITNESS VALUE OF A PROTEIN, RELATED COMPUTER PROGRAM PRODUCT

    CADET FREDERIC

    Query Match 96.3%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  45. US 9474755-B22016-10-25

    GLP-1 receptor modulators

    Celgene International II SARL

    Query Match 96.3%Identity 100.0%Family of 7

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 7

    Grouped by the same title and applicant. No priority claim is on record.

  46. US 9474780-B22016-10-25

    GIP and GLP-1 co-agonist compounds

    Eli Lilly and Company

    Query Match 96.3%Identity 100.0%Family of 8

    Best alignment and family

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

    Family of 8

    Grouped by the same title and applicant. No priority claim is on record.

  47. EP 3082797-A12016-10-26

    MODIFIED THERAPEUTIC AGENTS, STAPLED PEPTIDE LIPID CONJUGATES, AND COMPOSITIONS THEREOF

    CALIFORNIA INST FOR BIOMEDICAL RES

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  48. JP 2016535015-A2016-11-10

    LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME

    OPKO BIOLOGICS LTD,Fuad FARES,Udi Eyal FIMA

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  49. FXR AGONISTS AND METHODS FOR MAKING AND USING

    THE SALK INSTITUTE FOR BIOLOGICAL STUDIES

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  50. ANALOGS OF FEXARAMINE AND METHODS OF MAKING AND USING

    THE SALK INSTITUTE FOR BIOLOGICAL STUDIES

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.